GlassScriptPhysician profile
Brendan Powers O Connell
NPI 1356662936
$28,103.52
in general payments reported to CMS, 2019-2025
16 companies · $2,379 in 2025
The $2,379 reported for 2025 was more than what 91% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $2,758 · 2021: $1,559 · 2022: $702 · 2023: $911 · 2024: $3,221 · 2025: $2,379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,750 · Food and Beverage: $2,267 · Travel and Lodging: $1,494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,750.00 |
| Food and Beverage | $2,266.58 |
| Travel and Lodging | $1,494.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Med-El Corporation | $15,696.60 | 2019-2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit, Adhear Professional Kit |
| Medical Device Business Services, INC. | $9,553.93 | 2019 | |
| Cochlear Americas | $1,276.07 | 2021-2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant, Baha |
| Advanced Bionics, LLC | $453.17 | 2019-2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Medtronic, INC. | $318.88 | 2022-2025 | Stealthstation S8 Platform |
| Genzyme Corporation | $202.92 | 2023-2025 | |
| Optinose US, INC. | $166.29 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $149.05 | 2023-2025 | Dupixent |
| Acclarent, INC | $104.29 | 2021 | |
| Peerless Surgical INC. | $50.17 | 2021 | |
| Glaxosmithkline, LLC. | $47.27 | 2025 | Nucala |
| Ars Pharmaceuticals Operations, INC. | $22.47 | 2025 | Neffy |
| Checkpoint Surgical, INC | $17.42 | 2024 | Checkpoint Stimulators |
| Astrazeneca Pharmaceuticals LP | $16.14 | 2025 | |
| Hikma Pharmaceuticals USA | $14.74 | 2025 | Ryaltris |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $14.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brendan O Connell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.